This open letter from Greg Deavens, Independence CEO, and Robert Bogle, President and CEO of The Philadelphia Tribune, originally appeared in print on Sunday, August 1, 2021. The importance of the…
Read More
The Philadelphia Tribune and Independence Blue Cross (Independence) are continuing to address health disparities in the African American community with a new phase of their Our Community. Our Health campaign…
Independence Health Group (Independence) announces that Crystal E. Ashby has been appointed executive vice president and chief people officer. In this role, she will lead the company’s Human Resources division…
Show makes history with first outdoor event in 193 years Independence Blue Cross (Independence) is proud to again be an Executive Sponsor of the iconic Philadelphia Flower Show. Presented annually…
Independence Blue Cross (Independence) is continuing its award-winning Beat COVID-19 public service campaign with a new focus on vaccine awareness and education. The comprehensive campaign is using TV, print, digital/social…
This National Nurses Week, Independence Blue Cross (Independence) will shine a light on ten outstanding individuals through its annual Celebrate Caring campaign. This year’s campaign generated more submissions than ever…
Goal to Reduce Racial Disparities in Maternal Health by 50 percent in Five Years Philadelphia, PA — April 20 — Today, as part of its ongoing mission to improve the…
At Independence Blue Cross (Independence), we are deeply saddened and disheartened by the continued rise in violence and hateful rhetoric targeted against the Asian American Pacific Islander (AAPI) community. We…
Independence Blue Cross (Independence) and vybe urgent care (vybe) announce the opening of a COVID-19 vaccination site at Independence LIVE (1919 Market Street in Philadelphia), on the Independence Blue Cross…
By Victor Caraballo, M.D., VP of Quality Management, Independence Blue Cross A third FDA-authorized COVID-19 vaccine The U.S. Food and Drug Administration (FDA) has officially authorized the Johnson & Johnson…